Biovie Inc.
BIVI· Nasdaq
Filed May 10, 2021 · 10-Q · 40 days after period end · 0001520138-21-000255
| Metric | Q3 2021 | Q3 2020 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$2.99M | -$366.40K | -$178.50K | -$57.81K |
| EPS Diluted | -$0.22 | -$0.07 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 10, 2021 · 40 d after period end